|Table of Contents|

Correlation of tumor length and hypertension for cardiac myxoma embolism events

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 05
Page:
861-864
Research Field:
Publishing date:

Info

Title:
Correlation of tumor length and hypertension for cardiac myxoma embolism events
Author(s):
YUAN Changfen1; 2; XU Ying3; GUO Yunfan1; 4; HAO Shidan5; WANG Xiuyan2; WU Yuntao4; ZHANG Jingyi3
1.The Graduate School of North China University of Science and Technology,Hebei Tangshan 063000,China;2.Department of General Medicine;3.Department of Endocrinology;4.Department of Cardiovascular Medicine,Kailuan General Hospital Affiliated to North China University of Science and Technology,Hebei Tangshan 063000,China;5.Department of Endocrinology,Tangshan Hongci Hospital,Hebei Tangshan 063000,China.
Keywords:
cardiac myxoma; embolism events; tumor length; hypertension; predictive value
PACS:
R732.1
DOI:
10.3969/j.issn.1672-4992.2023.05.014
Abstract:
Objective：To explore the relationship between tumor characteristics,hypertension and embolic events in patients with cardiac myxoma.Methods:A total of 31 patients with cardiac myxoma diagnosed in Kailuan General Hospital Affiliated to North China University of Science and Technology from October 2004 to October 2020 were collected and divided into embolization group(n=8) and non-embolization group(n=23) according to the clinical characteristics of the patients.The relevant clinical indicators of the patients were collected,and Logistic regression analysis was performed.Results:There were significant differences between the two groups in tumor location,tumor length,and hypertension(P＜0.05).There was a positive correlation between tumor length,hypertension and embolism events(P＜0.05).Tumor length and hypertension were independent risk factors for embolism events(P＜0.05).The area under the ROC curve(AUC) of the logistic regression model for predicting the probability of embolism events was 0.902(95%CI:0.782~1.000,P＜0.01).Conclusion:Tumor length and hypertension affect the occurrence of embolism events in patients with cardiac myxoma.Combining these indicators to construct a regression model can improve the accuracy of evaluating embolic events in patients with cardiac myxoma.

References:

[1] POTERUCHA TJ,KOCHAV J,O'CONNOR DS,et al.Cardiac tumors:Clinical presentation,diagnosis and management［J］.Curr Treat Options Oncol,2019,20(8):66.
[2] TSENG IC,HUANG WJ,JHUANG YL,et al.Microinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma［J］.J Pathol,2017,242(2):134-139.
[3] AKDIS D,CHEN K,SAGUNER AM,et al.Clinical characteristics of patients with a right ventricular thrombus in arrhythmogenic right ventricular cardiomyopathy［J］.Thromb Haemost,2019,119(8):1373-1378.
[4] CHIARIELLO GA,BRUNO P,COLIZZI C,et al.Acute heart failure related to a large left atrial myxoma［J］.Proc(Bayl Univ Med Cent),2018,31(3):331-333.
[5] MCALLISTER BJ.Multi modality imaging features of cardiac myxoma［J］.J Cardiovasc Imaging,2020,28(4):235-243.
[6] KARABINIS A,SAMANIDIS G,KHOURY M,et al.Clinical presentation and treatment of cardiac myxoma in 153 patients［J］.Medicine(Baltimore),2018,97(37):e12397.
[7] BERNATCHEZ J，GAUDREAULT V，VINCENT G，et al． Left atrial myxoma presenting as an embolic shower:a case report and review of literature［J］.Ann Vasc Surg,2018,53:266.
[8] SAMANIDIS G,KHOURY M,BALANIKA M,et al.Current challenges in the diagnosis and treatment of cardiac myxoma［J］.Kardiol Pol,2020,78(4):269-277.
[9] LEE PT,HONG R,PANG PY,et al.Clinical presentation of cardiac myxoma in a Singapore national cardiac centre［J］.Singapore Med J,2021,62(4):195-198.
[10] BUSSANI R,CASTRICHINI M,RESTIVO L,et al.Cardiac tumors:Diagnosis,prognosis,and treatment［J］.Curr Cardiol Rep,2020,22(12):169.
[11] KALCIK M,BAYAM E,GUNER A,et al.Evaluation of the potential predictors of embolism in patients with left atrial myxoma［J］.Echocardiography,2019,36(5):837-843.
[12] ZHANG M,DING L,LIU Y,et al.Cardiac myxoma with glandular elements:a clinicopathological and immunohistochemical study of five new cases with an emphasis on differential diagnosis［J］.Pathol Res Pract,2014,210(1):55-58.
[13] YUAN SM,YAN SL,WU N.Unusual aspects of cardiac myxoma［J］.Anatol J Cardiol,2017,17(3):241-247.
[14] KHAN FAISAL AW,RIAZ W,NAVEED T,et al.Tricuspid valve myxoma:An uncommon presentation of a common tumour［J］.J Pak Med Assoc,2021,71(11):2669-2671.
[15] GRUBB KJ,JEVREMOVIC V,CHEDRAWY EG.Mitral valve myxoma presenting with transient ischemic attack:a case report and review of the literature［J］.J Med Case Rep,2018,12(1):363.
[16] LIU Y,WANG J,GUO L,et al.Risk factors of embolism for the cardiac myxoma patients:a systematic review and metanalysis［J］.BMC Cardiovasc Disord,2020,20(1):348.
[17] SAGRIS M,VARDAS EP,THEOFILIS P,et al.Atrial fibrillation:Pathogenesis,predisposing factors,and genetics［J］.Int J Mol Sci,2021,23(1):6.

Memo

Memo:
-
Last Update: 2023-01-31